Stimuli-responsive prodrug-based cancer nanomedicine

The rapid development of nanotechnology results in the emergence of nanomedicines, but the effective delivery of drugs to tumor sites remains a great challenge. Prodrug-based cancer nanomedicines thus emerged due to their unique advantages, including high drug load efficiency, reduced side effects,...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Angel, Hanif, Sumaira, Ouyang, Jiang, Tang, Zhongmin, Kong, Na, Kim, Na Yoon, Qi, Baowen, Patel, Dylan, Shi, Bingyang, Tao, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7280365/
https://www.ncbi.nlm.nih.gov/pubmed/32505922
http://dx.doi.org/10.1016/j.ebiom.2020.102821

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7280365/
https://www.ncbi.nlm.nih.gov/pubmed/32505922
http://dx.doi.org/10.1016/j.ebiom.2020.102821

Ejemplares similares